Xenon Pharmaceuticals Inc. has granted equity inducement awards to ten new non-officer employees, totaling 42,300 share options. The options have an exercise price of $40.74 per common share, reflecting the closing price on January 15, 2026. These share options vest over four years, with 25% vesting on the one-year anniversary of each employee's start date and the remainder vesting monthly over the following three years. Each option carries a 10-year term and is subject to the terms of the company’s Amended and Restated 2025 Inducement Equity Incentive Plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xenon Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9627358-en) on January 16, 2026, and is solely responsible for the information contained therein.